SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001385508-20-000057
Filing Date
2020-05-12
Accepted
2020-05-12 16:10:03
Documents
61
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q opnt0331202010q.htm 10-Q 614898
2 EXHIBIT 31.1 exhibit31103312020.htm EX-31.1 12548
3 EXHIBIT 31.2 exhibit31203312020.htm EX-31.2 12640
4 EXHIBIT 32.1 exhibit32103312020.htm EX-32.1 5819
5 EXHIBIT 32.2 exhibit32203312020.htm EX-32.2 5581
  Complete submission text file 0001385508-20-000057.txt   3455649

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT opnt-20200331.xml EX-101.INS 467558
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20200331.xsd EX-101.SCH 37375
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opnt-20200331_cal.xml EX-101.CAL 53159
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20200331_def.xml EX-101.DEF 208279
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20200331_lab.xml EX-101.LAB 446890
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20200331_pre.xml EX-101.PRE 309142
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38193 | Film No.: 20869185
SIC: 1000 Metal Mining